QTREX

QTREX is a specialty medical device company focused on the research, development, manufacturing, and commercialization of proprietary life support technologies. The company aims for its technology to supersede and revolutionize the global mechanical ventilation market. Mechanical ventilation is typically used when patients are unable to breathe adequately on their own due to acute respiratory failure and require assisted breathing from a machine. An estimated up to 20 million patients each year in ICUs are treated with invasive mechanical ventilation. Mortality rates among patients undergoing prolonged mechanical ventilation may exceed 50%. During mechanical ventilation, patients are generally placed under heavy sedation or medically induced coma, and a tube is inserted into the airway. The ventilator then delivers oxygen-rich air into the lungs to facilitate the transfer of oxygen into the bloodstream and vital organs. Patients can often experience complications associated with the use of mechanical ventilators, such as increased risk, costs of care, extended lengths of stay, frequent incidence of infections, ventilator dependence, and high mortality rates. Associated complications may include bacterial infections, lung damage, collapsed lung, and changes in heart and blood flow. Prolonged ventilation may involve replacing the tube from the mouth with a tube inserted through a small incision in the patient's neck. In cases where a patient is unlikely to recover, mechanical ventilation may prolong the dying process, potentially causing unnecessary suffering. QTREX's INSPIRA ART novel technology could potentially assist those ICU patients who are placed on mechanical ventilators.